跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Epiberberine
首页
药物
Epiberberine
Epiberberine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Synthetic method of epiberberine
申请人: BEIJING YILING PHARMACEUTICAL CO LTD
优先权: 2012
CN
Medical applications of epiberberine
申请人: SHANGHAI HUAJIN BIOTECHNOLOGY CO LTD
优先权: 2017
CN
Application of epiberberine, palmatine hydrochloride and composition of epiberberine and palmatine hydrochloride as antibacterial synergist
申请人: CHONGQING BULL ANIMAL PHARMACEUTICAL CO LTD
优先权: 2025
CN
Synthesis method and application of epiberberine
申请人: UNIV SOUTHWEST
优先权: 2019
CN
Application of epiberberine to preparation of helicobacter pylori infection resistant drug
申请人: UNIV SOUTHWEST
优先权: 2020
CN
Application of epiberberine in preparation of medicine for regulating hypererexia or treating obesity
申请人: SHANGHAI HOSPITAL TRADITIONAL CHINESE MEDICINE
优先权: 2021
CN
Application of epiberberine in prevention and treatment of intestinal injury caused by cadmium exposure
申请人: UNIV INNER MONGOLIA
优先权: 2025
CN
Application of epiberberine in preparation of medicine for treating or/and preventing diebetic complications or fatty liver
申请人: UNIV SOUTHWEST
优先权: 2020
CN
药物
反馈